Targeted Bevacizumab Therapy for Recurrent Vocal Fold Hemorrhage: First Case Report

^*Autor correspondiente de este trabajo

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Acceder al documento

@article{8c376edf01b34a1e8162f5b9b13111be,

title = "Targeted Bevacizumab Therapy for Recurrent Vocal Fold Hemorrhage: First Case Report",

keywords = "head and neck, laryngology, larynx, speech language pathology, voice disorders",

author = "\{Lanas Volz\}, Andr{\'e}s and \{Ram{\'i}rez Pelayo\}, Camila",

year = "2026",

doi = "10.1002/lary.70608",

language = "English",

journal = "Laryngoscope",

issn = "0023-852X",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Targeted Bevacizumab Therapy for Recurrent Vocal Fold Hemorrhage

T2 - First Case Report

AU - Lanas Volz, Andrés

AU - Ramírez Pelayo, Camila

PY - 2026

Y1 - 2026

KW - head and neck

KW - laryngology

KW - larynx

KW - speech language pathology

KW - voice disorders

UR - https://www.scopus.com/pages/publications/105038312050

U2 - 10.1002/lary.70608

DO - 10.1002/lary.70608

M3 - Article

AN - SCOPUS:105038312050

SN - 0023-852X

JO - Laryngoscope

JF - Laryngoscope

ER -